Jennifer A Johnson

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Beginning antiretroviral therapy for patients with HIV
    Jennifer A Johnson
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, PBBA4, Boston, MA 02115, USA Electronic address
    Infect Dis Clin North Am 28:421-38. 2014
  2. pmc Nonreplicating vectors in HIV vaccines
    Jennifer A Johnson
    Division of Infectious Diseases, Brigham and Women s Hospital, Beth Israel Deaconess Medical Center cHarvard Medical School, Boston, Massachusetts 02115, USA
    Curr Opin HIV AIDS 8:412-20. 2013
  3. pmc Gordonia bronchialis bacteremia and pleural infection: case report and review of the literature
    Jennifer A Johnson
    Division of Infectious Diseases, Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Clin Microbiol 49:1662-6. 2011
  4. ncbi request reprint First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)
    Lindsey R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, Massachusetts
    J Infect Dis 210:1052-61. 2014
  5. ncbi request reprint Antiretroviral therapy for treatment-naïve patients: a review of recent literature and the updated guidelines
    Jennifer A Johnson
    Division of Infectious Disease, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Curr Infect Dis Rep 11:311-8. 2009
  6. pmc First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
    Lindsey R Baden
    Brigham and Women s Hospital, Rockville, Maryland, USA
    J Infect Dis 207:240-7. 2013

Collaborators

  • Dan H Barouch
  • Stephen R Walsh
  • Michael S Seaman
  • June M Brown
  • Francisco M Marty
  • Lindsey R Baden
  • Mark Wolff
  • Raphael Dolin
  • Peter Abbink
  • Lauren Peter
  • Maria G Pau
  • Mo Weijtens
  • Robert P Tucker
  • Shringkhala Bajimaya
  • Jon A Gothing
  • Avinash Oza
  • Brittany R Carey
  • Jane A Kleinjan
  • Chelsea Bleckwehl
  • Brian A Engelson
  • Meghan Kunchai
  • Edith M Swann
  • Ann Cheung
  • Edith Swann
  • Alka Patel
  • Kathleen H Krause
  • Jane Kleinjan
  • Hayley Loblein
  • Jaap Goudsmit
  • James Perry
  • Katherine E Yanosick
  • Elise Zablowsky
  • M Justin Iampietro

Detail Information

Publications6

  1. ncbi request reprint Beginning antiretroviral therapy for patients with HIV
    Jennifer A Johnson
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, PBBA4, Boston, MA 02115, USA Electronic address
    Infect Dis Clin North Am 28:421-38. 2014
    ..In this article, we review the options for initial antiretroviral therapy, including the data from clinical trials to support these choices and the factors to consider in selection of a regimen to best fit each patient. ..
  2. pmc Nonreplicating vectors in HIV vaccines
    Jennifer A Johnson
    Division of Infectious Diseases, Brigham and Women s Hospital, Beth Israel Deaconess Medical Center cHarvard Medical School, Boston, Massachusetts 02115, USA
    Curr Opin HIV AIDS 8:412-20. 2013
    ..We review the broad spectrum of nonreplicating viral vectors which have been studied extensively, from preclinical studies through clinical efficacy trials, and include some of our most promising HIV vaccine candidates...
  3. pmc Gordonia bronchialis bacteremia and pleural infection: case report and review of the literature
    Jennifer A Johnson
    Division of Infectious Diseases, Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Clin Microbiol 49:1662-6. 2011
    ..We describe a case of Gordonia bronchialis bacteremia and pleural space infection in the absence of an indwelling intravascular catheter and review the breadth of reported infections with this emerging pathogen...
  4. ncbi request reprint First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)
    Lindsey R Baden
    Division of Infectious Diseases, Brigham and Women s Hospital Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, Massachusetts
    J Infect Dis 210:1052-61. 2014
    ....
  5. ncbi request reprint Antiretroviral therapy for treatment-naïve patients: a review of recent literature and the updated guidelines
    Jennifer A Johnson
    Division of Infectious Disease, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Curr Infect Dis Rep 11:311-8. 2009
    ....
  6. pmc First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
    Lindsey R Baden
    Brigham and Women s Hospital, Rockville, Maryland, USA
    J Infect Dis 207:240-7. 2013
    ..We report the first-in-human safety and immunogenicity assessment of a prototype Ad26 vector-based human immunodeficiency virus (HIV) vaccine in humans...